Natural Science Apr 29, 2021 The SARS-CoV-2 RNA interactome SARS-CoV-2 is an RNA virus whose success as a pathogen relies on its abilities to repurpose host RNA-binding proteins (RBPs) and to evade antiviral RBPs. Social Science Apr 08, 2021 From impossible to possible: How can South Korea track COVID-19? COVID-19 Tracking Policy and Privacy Infringement of South Korea Social Science Apr 08, 2021 Digitalization, e-government and the fight against Corona-lessions from Estonia Marti Mätas, Embassy of Estonia, Seoul National University, March 31, 2021 Social Science Mar 12, 2021 Estimation of the case fatality rate based on stratification for the COVID-19 outbreak This work is motivated by the recent worldwide pandemic of the novel coronavirus disease (COVID-19). When an epidemiological disease is prevalent, estimating the case fatality rate, the proportion of deaths out of the total cases, accurately and quickly is important as the case fatality rate is one of the crucial indicators of the risk of a disease. Medical Science Feb 02, 2021 Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals Stereotypic antibody clonotypes exist in healthy individuals and may provide protective immunity against viral infections by neutralization. We observed that 13 of 17 patients with COVID-19 had stereotypic variable heavy chain (VH) antibody clonotypes directed against the receptor binding domain (RBD) of SARS-CoV-2 spike protein. Natural Science Jan 12, 2021 The development of a new analysis method for mRNA which will make the COVID-19 Vaccines FAX-RIC enables robust profiling of dynamic RNP complex formation in multicellular organisms in vivo Medical Science Nov 02, 2020 SNU Webinar: Europe and WHO's response to COVID-19 SNU Responds to COVID-19, SNU Webinar: Europe and WHO's response to COVID-19, November 6th pm 4:00~5:30 Medical Science Oct 14, 2020 Estimating the Effectiveness of Non-Pharmaceutical Interventions on COVID-19 Control in Korea. The coronavirus disease 2019 (COVID-19) pandemic has posed significant global public health challenges and created a substantial economic burden. Medical Science Oct 14, 2020 Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity We hypothesized that immune response may contribute to progression of coronavirus disease-19 (COVID-19) at the second week of illness. Therefore, we compared cell-mediated immune (CMI) responses between severe and mild COVID-19 cases. Medical Science Oct 14, 2020 Information Technology–Based Management of Clinically Healthy COVID-19 Patients: Lessons From a Living and Treatment Support Center Operated by Seoul National University Hospital South Korea took preemptive action against coronavirus disease (COVID-19) by implementing extensive testing, thorough epidemiological investigation, strict social distancing, and rapid treatment of patients according to disease severity.